EP300 and prostate cancer: Here, we demonstrate that p300 functions as the essential HAT, defining active oncogenic enhanceosomes in prostate cancer by hyperacetylating the N terminus of histone H2B (H2BNT), thereby promoting oncogenic transcriptional programs.